Clinical Trial Detail

NCT ID NCT00356031
Title Bevacizumab and Radiation Therapy for Sarcomas
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors Massachusetts General Hospital
Indications

liposarcoma

leiomyosarcoma

fibrous histiocytoma

sarcoma

synovial sarcoma

fibrosarcoma

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.